Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis
- PMID: 4017162
- DOI: 10.1007/BF00257523
Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis
Abstract
The plasma level of 4'-O-tetrahydropyranyladriamycin (THP) declined rapidly after IV injection to mice, with a t1/2(alpha) of 0.453 min. Only 1.2 micrograms/ml THP was detected 2 min after injection of 5 mg/kg. The drug was immediately transferred to various tissues, where the drug levels were much higher than the plasma concentration. In the lung and spleen, 8.26 and 13.6 micrograms/g THP was present, respectively, 2 h after administration. Major metabolites of THP were 13-dihydro-THP, ADM, 7-deoxyadriamycinone, and 7-deoxy-13-dihydro-adriamycinone. Only 1.12% of the dose had been recovered in the urine by 48 h after injection as THP and its metabolites, according to analysis by HPLC fluorospectroscopy. The observed disposition of THP was compared with that of adriamycin (ADM). The plasma disappearance and tissue transfer of THP were faster than those of ADM. THP levels in the spleen and lung were higher and those in the heart and liver were lower than the corresponding ADM levels. Drug levels declined more quickly in most tissues in the case of THP than of ADM. Tissue distributions after single bolus and multiple injections were also compared and discussed.
Similar articles
-
Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer.Cancer Chemother Pharmacol. 1995;37(1-2):91-6. doi: 10.1007/BF00685634. Cancer Chemother Pharmacol. 1995. PMID: 7497603 Clinical Trial.
-
Pharmacokinetics and disposition of (2''R)-4'-O-tetrahydropyranyladriamycin in dogs.Jpn J Antibiot. 1986 Feb;39(2):638-52. Jpn J Antibiot. 1986. PMID: 3712763
-
[Pharmacokinetics and disposition of a new anticancer antibiotic (2''R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after a single administration].Jpn J Antibiot. 1986 Feb;39(2):612-28. Jpn J Antibiot. 1986. PMID: 3712761 Japanese.
-
[Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].Gan To Kagaku Ryoho. 1986 Feb;13(2):261-70. Gan To Kagaku Ryoho. 1986. PMID: 3947106 Japanese.
-
Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.Jpn J Antibiot. 1986 May;39(5):1321-36. Jpn J Antibiot. 1986. PMID: 3463778
Cited by
-
Phase I clinical trial and pharmacokinetic evaluation of 4'-0-tetrahydropyranyladriamycin (THP-adriamycin).Cancer Chemother Pharmacol. 1989;23(5):311-5. doi: 10.1007/BF00292410. Cancer Chemother Pharmacol. 1989. PMID: 2706737
-
Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer.Cancer Chemother Pharmacol. 1995;37(1-2):91-6. doi: 10.1007/BF00685634. Cancer Chemother Pharmacol. 1995. PMID: 7497603 Clinical Trial.
-
Antitumoral efficacy and pharmacokinetic properties of pirarubicin upon hepatic intra-arterial injection in the rabbit V x 2 tumour model.Br J Cancer. 1995 Mar;71(3):518-24. doi: 10.1038/bjc.1995.103. Br J Cancer. 1995. PMID: 7880733 Free PMC article.
-
Effects of anthracycline derivatives on hepatic neoplastic nodules of Lewis lung carcinoma and colon adenocarcinoma 26.Br J Cancer. 1991 Mar;63(3):363-6. doi: 10.1038/bjc.1991.86. Br J Cancer. 1991. PMID: 2003977 Free PMC article.
-
Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report.Children (Basel). 2023 May 12;10(5):871. doi: 10.3390/children10050871. Children (Basel). 2023. PMID: 37238419 Free PMC article.